The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin‐Norepinephrine Reuptake Inhibitors: American Headache Society Position PaperRandolph W. Evans, Gretchen E. Tietjen, Stewart J. Tepper et al.|Headache The Journal of Head and Face Pain|2010Cited by 126
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 StudiesTodd A. Smitherman, Eric Pearlman, Gretchen E. Tietjen et al.|Headache The Journal of Head and Face Pain|2020Cited by 35
Triptans and Serotonin Syndrome – A ResponseStewart J. Tepper, Gretchen E. Tietjen, Robert E. Shapiro et al.|Headache The Journal of Head and Face Pain|2012Cited by 2